RVLP

RVL Pharmaceuticals plc Ordinary Shares

Delisted

RVLP was delisted on the 20th of October, 2023.

36 hedge funds and large institutions have $27.8M invested in RVL Pharmaceuticals plc Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$111K
Puts
$6K
Net Calls
Net Calls Change

Top Buyers

1 +$1.05M
2 +$203K
3 +$185K
4
BlackRock
BlackRock
New York
+$91.6K
5
Charles Schwab
Charles Schwab
California
+$56K

Top Sellers

1 -$1.22M
2 -$624K
3 -$275K
4
Morgan Stanley
Morgan Stanley
New York
-$156K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$76.5K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$13.8M
2
$5.07M
3
$2.74M
4
$2.15M
5
$1.67M
6
$427K
7
$358K
8
$352K
9
$203K
10
$175K
11
$147K
12
$127K
13
$123K
14
$66K
15
$64K
16
$60K
17
$56K
18
$46K
19
$40K
20
$32K
21
$30K
22
$20K
23
$19K
24
$17K
25
$7K